Author:
Durmus Selvi,Hendrikx Jeroen J.M.A.,Schinkel Alfred H.
Reference139 articles.
1. Breast cancer resistance protein and P-glycoprotein in brain cancer: Two gatekeepers team up;Agarwal;Current Pharmaceutical Design,2011
2. Distribution of gefitinib to the brain is limited by P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2)-mediated active efflux;Agarwal;The Journal of Pharmacology and Experimental Therapeutics,2010
3. Quantitative proteomics of transporter expression in brain capillary endothelial cells isolated from P-glycoprotein (P-gp), breast cancer resistance protein (Bcrp), and P-gp/Bcrp knockout mice;Agarwal;Drug Metabolism and Disposition,2012
4. Mouse breast cancer resistance protein (Bcrp1/Abcg2) mediates etoposide resistance and transport, but etoposide oral availability is limited primarily by P-glycoprotein;Allen;Cancer Research,2003
5. Increased oral bioavailability of paclitaxel by GF120918 in mice through selective modulation of P-glycoprotein;Bardelmeijer;Clinical Cancer Research,2000
Cited by
85 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献